Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abbott LaboratoriesXSWX:ABT 78 3-Year Dividend Growth Rate is 7.90% as of Jun. 2026, which is 27% below its 10-year median of 10.80. GuruFocus rates XSWX:ABT with a GF Score™ of 78/100 and a GF Value™ of CHF105.66. The stock has 2 warning signs investors should review. Among 223 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 54.26% on this metric.
The historical rank and industry rank for Abbott Laboratories's 3-Year Dividend Growth Rate or its related term are showing as below:
XSWX:ABT'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -31.2 Med: 10.8 Max: 22.9
Current: 7.9
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Abbott Laboratories was 22.90% per year. The lowest was -31.20% per year. And the median was 10.80% per year.
XSWX:ABT's 3-Year Dividend Growth Rate is ranked better than 54.26% of 223
companies
in the Medical Devices & Instruments industry
Industry Median: 5.6
vs XSWX:ABT: 7.90
During the past 12 months, Abbott Laboratories's average Dividends Per Share Growth Rate was 7.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 7.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 9.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 10.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Abbott Laboratories was 0.47. The lowest was 0.35. And the median was 0.41.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Abbott Laboratories Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.630000
2026-07-15
2026-07-15
2026-08-17
Cash Dividend
quarterly
USD:CHF 0.808100
USD 0.630000
2026-04-15
2026-04-15
2026-05-15
Cash Dividend
quarterly
USD:CHF 0.782400
USD 0.630000
2026-01-15
2026-01-15
2026-02-13
Cash Dividend
quarterly
USD:CHF 0.771000
USD 0.590000
2025-10-15
2025-10-15
2025-11-17
Cash Dividend
quarterly
USD:CHF 0.802700
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Abbott Laboratories's Dividend Yield (%) for Today is calculated as
Current Share Price is CHF93.00.
Abbott Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF1.961338.
During the past 13 years, the highest Dividend Yield of Abbott Laboratories was 2.85%. The lowest was 1.12%. And the median was 1.73%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories 3-Year Dividend Growth Rate Related Terms>
XSWX:ABT vs SYK, MDT, BSX: 3-Year Dividend Growth Rate Comparison
For the Medical Devices subindustry, Abbott Laboratories's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories 3-Year Dividend Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 7.90% mean?
Abbott Laboratories (XSWX:ABT) has a 3-Year Dividend Growth Rate of 7.90% as of Jun. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Abbott Laboratories and its competitors. This is 27% below median its historical median of 10.80. According to the industry distribution chart, Abbott Laboratories ranks #102 out of 223 companies in the Medical Devices & Instruments industry, placing it in the top 45.7%.
Is Abbott Laboratories' 3-Year Dividend Growth Rate too high?
Abbott Laboratories' current 3-Year Dividend Growth Rate of 7.90% is 27% below median its 10-year median of 10.80. The Medical Devices & Instruments industry median 3-Year Dividend Growth Rate is 5.60. Abbott Laboratories' value of 7.90% is 41.1% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #102 out of 223 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' 3-Year Dividend Growth Rate compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #102 out of 223 companies for 3-Year Dividend Growth Rate. This puts Abbott Laboratories in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 5.60. Abbott Laboratories' value of 7.90% is 41.1% above this benchmark. While the company's 10-year median is 10.80 vs. the industry median of 5.60, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Dividend Growth Rate among Medical Devices & Instruments companies is 5.60, based on 223 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current 3-Year Dividend Growth Rate of 7.90% is 41.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Dividend Growth Rate is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current 3-Year Dividend Growth Rate is 7.90%, which is 27% below median its own 10-year median of 10.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current 3-Year Dividend Growth Rate of 7.90%. The stock's GF Value™ is CHF105.66, compared to a current price of CHF93.00 — trading 12% below its estimated fair value. The current 3-Year Dividend Growth Rate is 7.90%, which is 27% below median its 10-year median of 10.80 and 41.1% above the Medical Devices & Instruments industry median of 5.60. Abbott Laboratories' overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current 3-Year Dividend Growth Rate is 7.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF93.00 is trading 12% below its estimated GF Value™ of CHF105.66.
Key valuation signals for XSWX:ABT:
3-Year Dividend Growth Rate: 7.90% (27% below median its 10-year median of 10.80)
GF Value™: CHF105.66 vs. price of CHF93.00 (12% below fair value)
Industry Position: 41.1% above the Medical Devices & Instruments median (#102 of 223)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
78GF Score
Get the complete analysis for XSWX:ABT
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
